Association Studies on Gut and Lung Microbiomes in Patients with Lung Adenocarcinoma

Lung adenocarcinoma (LADC) is a prevalent type of lung cancer that is associated with lung and gut microbiota. However, the interactions between these microbiota and cancer development remain unclear. In this study, a microbiome study was performed on paired fecal and bronchoalveolar lavage fluid (BALF) samples from 42 patients with LADC and 64 healthy controls using 16S rRNA gene amplicon and shotgun metagenome sequencing, aiming to correlate the lung and gut microbiota with LADC. Patients with LADC had reduced α-diversity in the gut microbiome and altered β-diversity compared with healthy controls, and the abundances of <i>Flavonifractor</i>, <i>Eggerthella</i>, and <i>Clostridium</i> were higher in the gut microbiome of LADC patients. The increased abundance of microbial species, such as <i>Flavonifractor plautii</i>, was associated with advanced-stage LADC and a higher metastasis rate. Phylogenetically, <i>Haemophilus parainfluenzae</i> was the most frequently shared taxon in the lung and gut microbiota of LADC patients. Gut microbiome functional pathways involving leucine, propanoate, and fatty acids were associated with LADC progression. In conclusion, the low diversity of the gut microbiota and the presence of <i>H. parainfluenzae</i> in gut and lung microbiota were linked to LADC development, while an increased abundance of <i>F. plautii</i> and the enriched metabolic pathways could be associated with the progression of LADC.